Internal Medicine, Cardiovascular Disease · Birmingham, AL
NPI
1255305470
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
833 Saint Vincents Dr Ste 300, Pob III
Birmingham, AL, 35205
Phone (205) 939-4512
Groups this clinician bills Medicare through
Medicare paid, 2024
$379K
9,150 services
Medicare patients, 2024
1,204
Average age 78
Drug cost, 2024
$1.7M
10,435 prescriptions
Company payments, 2025
$1,829
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James M Parks was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,377 times for 673 patients. In total James M Parks billed 9,150 services in 103 codes, and Medicare paid $379K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,377 | 673 | $10.86 | $15K |
| 99213 Office E&M - Established | Office | 1,145 | 614 | $55.40 | $63K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 594 | 299 | $89.03 | $53K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 584 | 146 | $5.61 | $3,277 |
| 99214 Office E&M - Established | Office | 322 | 263 | $85.90 | $28K |
| 93015 Electrocardiogram | Office | 248 | 246 | $43.81 | $11K |
| 78452 Myocardial Perfusion Scan | Office | 240 | 238 | $286.72 | $69K |
| 93306 Echocardiography (TTE/TEE) | Office | 162 | 161 | $124.13 | $20K |
| 93296 External Electrocardiographic Monitoring | Office | 160 | 85 | $13.34 | $2,135 |
| 93294 External Electrocardiographic Monitoring | Office | 155 | 82 | $19.76 | $3,063 |
| 93306 Echocardiography (TTE/TEE) | Facility | 121 | 118 | $46.45 | $5,620 |
| 99232 Hospital E&M - Subsequent | Facility | 108 | 63 | $57.48 | $6,207 |
| 99222 Hospital E&M - Initial | Facility | 93 | 83 | $94.89 | $8,824 |
| 93280 External Electrocardiographic Monitoring | Office | 58 | 43 | $52.13 | $3,023 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 56 | 28 | $83.36 | $4,668 |
By year: 2022 $416K for 5,821 services; 2023 $397K for 6,866 services; 2024 $379K for 9,150 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 46 | 43 | $8.65 | $398 |
| 80061 Clinical Chemistry | 25 | 23 | $12.66 | $317 |
| 80076 Clinical Chemistry | 14 | 14 | $8.01 | $112 |
| 80048 Clinical Chemistry | 11 | 11 | $8.29 | $91.19 |
Medicare prescription drug claims, 2024
In 2024, the drug James M Parks prescribed most often to Medicare patients was Metoprolol Succinate, with 1,289 prescriptions and refills. In total James M Parks wrote 10,435 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,289 | 2,988 | 341 | $23K |
| Eliquis Apixaban | 891 | 1,238 | 161 | $704K |
| Clopidogrel Clopidogrel Bisulfate | 731 | 1,939 | 216 | $8,971 |
| Atorvastatin Calcium Generic | 700 | 1,893 | 221 | $11K |
| Losartan Potassium Generic | 608 | 1,522 | 181 | $7,594 |
| Amlodipine Besylate Generic | 565 | 1,297 | 158 | $3,769 |
| Entresto Sacubitril/Valsartan | 469 | 583 | 68 | $379K |
| Furosemide Generic | 454 | 934 | 126 | $2,062 |
| Hydrochlorothiazide Generic | 370 | 854 | 114 | $1,750 |
| Carvedilol Generic | 275 | 698 | 91 | $2,944 |
| Metoprolol Tartrate Generic | 253 | 662 | 80 | $1,916 |
| Clonidine Generic | 239 | 365 | 45 | $32K |
| Lisinopril Generic | 239 | 658 | 70 | $2,219 |
| Rosuvastatin Calcium Generic | 235 | 580 | 72 | $3,816 |
| Nitroglycerin Generic | 196 | 216 | 131 | $2,402 |
Brand drugs: 2,069 claims; generic drugs: 8,366 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James M Parks $1,829 ($1,829 in general payments such as food, travel and fees) from 18 companies. The largest payer was Novartis Pharmaceuticals Corporation with $223.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 11 | $223 |
| Novo Nordisk Inc NVO | 9 | $205 |
| Pfizer Inc. PFE | 10 | $197 |
| Edwards Lifesciences Corporation EW | 4 | $181 |
| Amgen Inc. AMGN | 12 | $177 |
| Merck Sharp & Dohme LLC MRK | 7 | $130 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $121 |
| Alnylam Pharmaceuticals Inc. ALNY | 6 | $117 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $108 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.